Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Crispen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|July 6, 1974
Letter: Immunotherapy with intravenous B.C.GR G Crispen
The Journal of Urology|March 1, 1984
Re: Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinomaR G Crispen
Developments in Biological Standardization|January 1, 1986
Qualitative effect of BCG vaccination on sensitivity to typical and atypical tuberculinsR G Crispen
IMJ. Illinois Medical Journal|April 1, 1976
BCG vaccine. Past, present, futureR G Crispen
Seminars in Oncology|December 1, 1974
BCG vaccine in perspectiveR G Crispen
Developments in Biological Standardization|January 1, 1986
BCG and cancerR G Crispen
The American Surgeon|July 1, 1978
Survival of patients with bronchogenic carcinoma modified by BCG immunotherapyS E Warren, R G Crispen, B Nika
The American Review of Respiratory Disease|January 1, 1987
Tuberculosis in physicians. Compliance with preventive measuresP J Geiseler, K E Nelson, R G Crispen
Infection and Immunity|February 1, 1986
Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generationT J Holzer, K E Nelson, R G Crispen, et al.
The Journal of Urology|February 1, 1986
Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancerD L Lamm, V D Stogdill, B J Stogdill, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|July 6, 1974
Letter: Immunotherapy with intravenous B.C.GR G Crispen
The Journal of Urology|March 1, 1984
Re: Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinomaR G Crispen
Developments in Biological Standardization|January 1, 1986
Qualitative effect of BCG vaccination on sensitivity to typical and atypical tuberculinsR G Crispen
IMJ. Illinois Medical Journal|April 1, 1976
BCG vaccine. Past, present, futureR G Crispen
Seminars in Oncology|December 1, 1974
BCG vaccine in perspectiveR G Crispen
Developments in Biological Standardization|January 1, 1986
BCG and cancerR G Crispen
The American Surgeon|July 1, 1978
Survival of patients with bronchogenic carcinoma modified by BCG immunotherapyS E Warren, R G Crispen, B Nika
The American Review of Respiratory Disease|January 1, 1987
Tuberculosis in physicians. Compliance with preventive measuresP J Geiseler, K E Nelson, R G Crispen
Infection and Immunity|February 1, 1986
Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generationT J Holzer, K E Nelson, R G Crispen, et al.
The Journal of Urology|February 1, 1986
Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancerD L Lamm, V D Stogdill, B J Stogdill, et al.
Pageof 2